PEGINTERFERON ALFA-2B\RIBAVIRIN: 55 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
55
Total FAERS Reports
7 (12.7%)
Deaths Reported
27
Hospitalizations
55
As Primary/Secondary Suspect
5
Life-Threatening
3
Disabilities
First Report: 2005 · Latest Report: 20180418
What Are the Most Common PEGINTERFERON ALFA-2B\RIBAVIRIN Side Effects?
#1 Most Reported
Nausea
13 reports (23.6%)
#2 Most Reported
Hepatic failure
13 reports (23.6%)
#3 Most Reported
Fatigue
11 reports (20.0%)
All PEGINTERFERON ALFA-2B\RIBAVIRIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatic failure | 13 | 23.6% | 5 | 12 |
| Nausea | 13 | 23.6% | 3 | 8 |
| Abdominal pain | 11 | 20.0% | 0 | 8 |
| Fatigue | 11 | 20.0% | 3 | 4 |
| Off label use | 10 | 18.2% | 0 | 8 |
| Renal failure | 9 | 16.4% | 1 | 9 |
| Blood test abnormal | 8 | 14.6% | 0 | 8 |
| Chills | 8 | 14.6% | 2 | 8 |
| Diarrhoea | 8 | 14.6% | 1 | 7 |
| Drug ineffective | 8 | 14.6% | 0 | 3 |
| Pyrexia | 8 | 14.6% | 2 | 8 |
| Headache | 7 | 12.7% | 3 | 3 |
| Hepatic function abnormal | 7 | 12.7% | 0 | 7 |
| Hepatorenal syndrome | 7 | 12.7% | 1 | 6 |
| Anaemia | 6 | 10.9% | 0 | 5 |
| Hepatitis c | 6 | 10.9% | 0 | 2 |
| International normalised ratio increased | 6 | 10.9% | 0 | 6 |
| Jaundice | 6 | 10.9% | 1 | 5 |
| Malaise | 6 | 10.9% | 2 | 4 |
| Portal vein thrombosis | 6 | 10.9% | 0 | 6 |
Who Reports PEGINTERFERON ALFA-2B\RIBAVIRIN Side Effects? Age & Gender Data
Gender: 61.3% female, 38.8% male. Average age: 53.1 years. Most reports from: CA. View detailed demographics →
Is PEGINTERFERON ALFA-2B\RIBAVIRIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2005 | 2 | 0 | 0 |
| 2008 | 1 | 0 | 0 |
| 2012 | 2 | 0 | 1 |
| 2013 | 2 | 0 | 1 |
| 2014 | 8 | 2 | 6 |
| 2015 | 2 | 0 | 1 |
| 2018 | 1 | 0 | 0 |
What Is PEGINTERFERON ALFA-2B\RIBAVIRIN Used For?
| Indication | Reports |
|---|---|
| Hepatitis c | 24 |
| Chronic hepatitis c | 14 |
| Product used for unknown indication | 10 |
Official FDA Label for PEGINTERFERON ALFA-2B\RIBAVIRIN
Official prescribing information from the FDA-approved drug label.